Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif.
Fiche du document
2007
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0000645
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/17653272
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1932-6203[electronic], 1932-6203[linking]
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_8ED3445AE0F04
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Immune globulins Antibodies Immune serum globulinCiter ce document
V. Villard et al., « Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif. », Serveur académique Lausannois, ID : 10.1371/journal.pone.0000645
Métriques
Partage / Export
Résumé
To identify malaria antigens for vaccine development, we selected alpha-helical coiled coil domains of proteins predicted to be present in the parasite erythrocytic stage. The corresponding synthetic peptides are expected to mimic structurally "native" epitopes. Indeed the 95 chemically synthesized peptides were all specifically recognized by human immune sera, though at various prevalence. Peptide specific antibodies were obtained both by affinity-purification from malaria immune sera and by immunization of mice. These antibodies did not show significant cross reactions, i.e., they were specific for the original peptide, reacted with native parasite proteins in infected erythrocytes and several were active in inhibiting in vitro parasite growth. Circular dichroism studies indicated that the selected peptides assumed partial or high alpha-helical content. Thus, we demonstrate that the bioinformatics/chemical synthesis approach described here can lead to the rapid identification of molecules which target biologically active antibodies, thus identifying suitable vaccine candidates. This strategy can be, in principle, extended to vaccine discovery in a wide range of other pathogens.